.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Breez has demonstrated a consistent performance in the California market, particularly in the Capsules category, where it has maintained its position as the second-ranked brand from March to June 2024. This stability highlights Breez's strong foothold in the Capsules segment within California. In contrast, the brand's performance in the Edible category has seen slight improvements, moving from 42nd place in March to 39th place in June. However, it is noteworthy that Breez did not break into the top 30 in this category, indicating room for growth. The Tincture & Sublingual category has shown consistent rankings, with Breez holding the 13th position throughout the four months, though a notable decline in sales figures suggests potential challenges in maintaining market share.
In Illinois, Breez's performance in the Capsules category has been more dynamic. The brand was not ranked in March but made a significant entry into the market in April, securing the 4th position and maintaining it through May and June. This rapid ascent highlights a strong acceptance and growing demand for Breez's Capsules in Illinois. The lack of data for the Edible and Tincture & Sublingual categories in Illinois suggests that Breez has yet to establish a significant presence in these segments. Overall, Breez's performance across these states and categories indicates both strengths in certain areas and opportunities for expansion and improvement in others.
Competitive Landscape
In the competitive landscape of cannabis capsules in California, Breez has consistently maintained its position as the second-ranked brand from March to June 2024. Despite a slight decline in sales from $1,475,434 in March to $1,348,743 in June, Breez's stability in rank highlights its strong market presence. In comparison, Level has held the top spot throughout the same period, with sales figures consistently higher than Breez, peaking at $1,703,795 in April. Meanwhile, ABX / AbsoluteXtracts and Kikoko have shown more volatility, with ABX dropping in sales and maintaining the fourth rank, while Kikoko experienced a notable rise to third place in June. This competitive analysis underscores Breez's robust market position amidst fluctuating performances from its competitors, suggesting a loyal customer base and effective market strategies.
Notable Products
In June 2024, Breez's top-performing product was the Indica Extra Strength Tablet 50-Pack (1000mg), maintaining its first-place ranking for four consecutive months with a sales figure of $9002. The Sativa Extra Strength Tablet 50-Pack (1000mg) also held steady in second place, though its sales decreased to $8003 from previous months. The Hybrid Extra-Strength Tablet 50-Pack (1000mg) remained in third place, but saw a notable drop in sales to $7031. New to the top rankings, Pineapple Breeze (3.5g) entered at fourth place, while the CBD/THC 1:1 Relief Extra Strength Tablets 50-Pack (500mg CBD, 500mg THC) debuted in fifth place. This shift indicates a growing interest in both flower products and balanced CBD/THC offerings.
Top Selling Cannabis Brands
